Key Record Dates Identifier: NCT02411656
Brief Title: Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

First Submitted : April 3, 2015
First Submitted that Met QC Criteria : April 3, 2015
First Posted : April 8, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : December 4, 2020
Last Update Posted : December 7, 2020